Developer docs
API playgroundTry for free, no card

Search company profiles

MethodSense

Full company profile

uuid000a4nr

Namestring
MethodSense
Legal namestring
MethodSense, Inc.
Websiteurl
methodsense.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

MethodSense is a privately held regulatory and quality consulting firm founded in 2000 and headquartered in Morrisville, NC. The firm is led by founders Rita King (CEO) and Russ King (President) and has spent over 25 years helping medical device companies navigate FDA, EU MDR, ISO 13485, and related quality and compliance frameworks. Its customer base spans medical device startups, growth-stage companies, large enterprises, and an expanding footprint with investors and industry partners.

The company's core product is LuminLogic NextGen, an AI-enabled electronic Quality Management System (eQMS) and Regulatory Compliance Platform. Underlying components include LuminLogic IQ (an AI-powered regulatory intelligence module supporting knowledge retrieval, process automation, and generative AI), a structured Knowledge Base, and the Elsa & AI Resource Center for AI/ML SaMD compliance content. The platform is designed to host QMS records, design history files, and regulatory submission workflows for medical device manufacturers.

MethodSense monetizes through three streams: (1) regulatory and quality consulting engagements, (2) SaaS licensing of the LuminLogic platform, and (3) a recently launched Capital & Investment Strategy Advisory practice targeting VC, PE, and strategic acquirers. Pricing is quote-based with multi-year contracts and flexible engagement models. Geographic reach is extended through an affiliate network including mdi Europa (EU) and Klass Consulting (Turkey/Russia), and the firm has been recognized with a Global Reach Award from the North Carolina Governor. Recent strategic emphasis has been on commercializing the LuminLogic platform, scaling investor-facing advisory services, and building partner channels within the medtech investment ecosystem.

Short descriptiontext

MethodSense is a regulatory and quality consulting firm serving medical device companies via LuminLogic, an AI-enabled eQMS and compliance platform, alongside FDA, EU MDR, and ISO advisory services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMorrisville, United States
HQ citystring
Morrisville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device regulatory consulting, quality management systems, FDA submission support, eQMS compliance software, MedTech commercialization services
Industry3 codes
1Regulatory Operations & Publishing (eCTD, RIM, Submission Management)
CodeHLAGAKACPrimaryYes
2Regulatory Affairs & Submissions FSP
CodeHLAGAOADPrimaryNo
3Regulatory Submissions & Clinical Content Management (eCTD/Publishing)
CodeHLACAOANPrimaryNo
NAICS code2 codes
  • Management Consulting Services54161
  • Computer Systems Design Services541512
SIC code2 codes
  • Services-Management Consulting Services8742
  • Services-Prepackaged Software7372
Product category
Medical Device Regulatory Compliance
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Regulatory & Quality Consulting Services
TypeProfessional Services
Description

Professional consulting services for regulatory strategy, FDA submissions, quality management systems, and compliance support. Delivered through embedded support, project-based consulting, fractional expertise, and on-call guidance models.

methodsense.com
2LuminLogic Platform Licensing
TypeSubscription Recurring
Description

SaaS licensing of the AI-enabled eQMS and regulatory compliance platform. Organizations can license LuminLogic to continue managing projects, quality systems, and regulatory activities after consulting engagement concludes.

methodsense.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Pricing details1 tier
1Flexible engagement models - embedded, project-based, fractional, on-call
ModelOtherBilling cadenceMulti-year contract
Notes

Consulting services priced based on engagement type: Embedded Support (ongoing integration with client teams), Project-Based Consulting (fixed deliverables with milestone-driven timelines), Fractional Expertise (senior leadership access without full-time overhead), On-Call Guidance (as-needed access to specialists). No public pricing disclosed.

methodsense.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1LuminLogic
Description

AI-enabled eQMS and Regulatory Compliance Platform purpose-built for medical device companies. Developed by MethodSense, it captures more than 25 years of regulatory, quality, and commercialization expertise. LuminLogic is a registered trademark of MethodSense, Inc.

methodsense.com
Core offering1 text field

MethodSense combines regulatory and quality consulting services with the LuminLogic® NextGen AI-enabled eQMS and Regulatory Compliance Platform purpose-built for medical device organizations. The offering includes regulatory strategy, FDA submissions and clearance support, quality management system implementation, submission disciplines, business strategy, and specialty services in AI/ML, cybersecurity, SaMD, and combination products, supported by a SaaS platform that connects Regulatory, Quality, Engineering, Clinical, Manufacturing, and Leadership teams.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Reduced time-to-clearance by up to 40%
+3 more records
Product overview1 text field

MethodSense offers a unified platform-plus-services model centered on LuminLogic® NextGen, an AI-enabled eQMS and Regulatory Compliance Platform purpose-built for medical device companies. The platform combines more than 25 years of regulatory, quality, and commercialization expertise into connected workflows. Key components include LuminLogic IQ (AI-powered intelligence module), the Knowledge Base service, and integrated consulting services spanning Regulatory Strategy & Product Clearance, Quality Management & Business Operations, Submission Disciplines and Support, Business Strategy & Project Management, Capital & Investment Strategy for MedTech, and Specialty Services (AI/ML Validation, Cybersecurity, IEC 60601-1, Combination Products). The platform enables real-time executive visibility through live dashboards and maintains complete traceability across the product lifecycle from concept to clearance.

Product and service7 records
1LuminLogic NextGen
CategoryCompliance Management Software
Description

AI-enabled eQMS and Regulatory Compliance Platform purpose-built for medical device organizations. Connects Regulatory, Quality, Engineering, Clinical, Manufacturing, and Leadership teams through a single operational platform with AI-powered intelligence, connected workflows, and real-time executive visibility.

2LuminLogic Knowledge Base
CategoryCompliance Management Software
Description

Enhanced knowledge base service on the LuminLogic platform that supports regulatory documentation, content management, and information retrieval across the product lifecycle.

3Regulatory Strategy and Product Clearance Consulting
CategoryRegulatory Consulting Services
Description

Professional consulting services for regulatory strategy, FDA submission preparation, pathway determination, and product clearance for medical device companies. Delivered through embedded, project-based, fractional, and on-call engagement models.

4Quality Management and Business Operations Consulting
CategoryQuality Management Consulting Services
Description

Consulting services for quality management system (QMS) implementation, ISO 13485 certification, internal gap assessments, supplier oversight, and operational process improvements for medical device companies.

5Submission Disciplines and Support Consulting
CategoryRegulatory Submission Services
Description

Consulting services supporting FDA, EU MDR, eSTAR, ISO 13485, and other global submissions including 510(k), CE Mark, and stalled submission recovery for medical device companies.

6Capital and Investment Strategy Advisory for MedTech
CategoryInvestment Advisory Services
Description

Advisory practice aligning regulatory intelligence with fundable growth and confident capital deployment for the MedTech sector, supporting investors and MedTech companies on regulatory due diligence, QMS documentation review, acquisition preparation, and valuation support.

7Specialty Services (AI/ML Validation, Cybersecurity, IEC 60601-1, Combination Products)
CategorySpecialty Regulatory Consulting Services
Description

Specialty consulting services covering AI/ML validation, cybersecurity compliance, IEC 60601-1, combination products, SaMD, and software lifecycle documentation for medical device companies.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

mdi Europa serves as European Authorized Representative, helping global medical device manufacturers meet EU MDR and IVDR requirements. Their experienced team has supported CE Marking for hundreds of companies, from startups to established brands. Partnership enables MethodSense to offer comprehensive EU market access support.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Klass Consulting helps medical device companies enter European markets, Turkey, and Russia. Core services include distributor identification and management, as well as reimbursement and global marketing strategy support. Extends MethodSense's European market entry capabilities.

Strategic tierSupportingTypeImplementation/ SI/ Consulting Partner
Description

Provides evaluation, testing, and compliance reporting for FDA, Health Canada, and international regulatory bodies, supporting CE Marking and global approvals. Complements MethodSense's regulatory and quality services with testing and compliance assessment capabilities.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Clinical research partners supporting clinical strategy, trial design, execution, and data analysis. Extend MethodSense's capability to support clinical evidence generation for regulatory submissions.

Strategic tierSupportingTypeImplementation/ SI/ Consulting Partner
Description

Partners ensuring products are safe, effective, and user-centered through research and validation. Support usability studies and human factors documentation for regulatory submissions.

Strategic tierSupportingTypeTechnology or Integration
Description

Specialists guiding compliant development and verification of software as a medical device (SaMD) and embedded systems. Support cybersecurity and software lifecycle documentation.

Strategic tierSupportingTypeImplementation/ SI/ Consulting Partner
Description

Partners strengthening internal processes with audits, gap assessments, and customized staff training. Extend MethodSense's quality management system implementation capabilities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight12 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Veeva is a large, publicly traded life sciences cloud platform with quality, regulatory, and clinical suites used by major MedTech and pharma companies — a broader incumbent competing for the same enterprise eQMS and RIM budgets as LuminLogic.

TypeDirect peer
Description

MasterControl provides enterprise-grade eQMS, document control, and regulatory submission management for life sciences manufacturers, including dedicated MedTech modules — competing with LuminLogic in the same procurement cycles.

TypeDirect peer
Description

Rimsys offers SaaS for medical device regulatory affairs, including submission planning, registration tracking, and standards management — a direct competitor to MethodSense's submission automation and eSTAR support capabilities.

TypeEmerging player
Description

Dot Compliance delivers AI-powered, ready-to-use eQMS solutions on the Salesforce platform for life sciences — an emerging competitor to LuminLogic with a similar AI-augmented quality and compliance positioning.

TypeDirect peer
Description

ProPharma Group provides regulatory, compliance, and quality consulting across pharma and MedTech, including FDA submission support and QMS implementation — directly comparable to MethodSense's consulting service lines.

TypeDirect peer
Description

Greenlight Guru is a MedTech-specific eQMS and quality management platform offering similar SaaS-based regulatory and quality workflows for medical device companies — directly comparable to MethodSense's LuminLogic offering.

TypeBroad incumbent
Description

IQVIA is a global CRO and life sciences services giant with extensive regulatory affairs consulting capabilities — comparable to MethodSense's professional services arm and competing for the same MedTech regulatory outsourcing spend.

TypeDirect peer
Description

RCA specializes in regulatory affairs and quality system consulting for medical device and life sciences companies, including FDA submissions and ISO 13485 — a direct peer to MethodSense's core consulting practice.

TypeDirect peer
Description

NAMSA is a MedTech-focused CRO and regulatory consulting firm offering preclinical, clinical, and regulatory services to medical device manufacturers — overlapping with MethodSense's regulatory strategy and submission support offerings.

TypeBroad incumbent
Description

Medidata, part of Dassault Systèmes, provides clinical and regulatory platforms for life sciences organizations — a broad incumbent whose regulatory and submission tools overlap with portions of the LuminLogic platform.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MethodSense

Medical Device Regulatory Compliancemethodsense.com

MethodSense is a regulatory and quality consulting firm serving medical device companies via LuminLogic, an AI-enabled eQMS and compliance platform, alongside FDA, EU MDR, and ISO advisory services.

What MethodSense does

MethodSense is a privately held regulatory and quality consulting firm founded in 2000 and headquartered in Morrisville, NC. The firm is led by founders Rita King (CEO) and Russ King (President) and has spent over 25 years helping medical device companies navigate FDA, EU MDR, ISO 13485, and related quality and compliance frameworks. Its customer base spans medical device startups, growth-stage companies, large enterprises, and an expanding footprint with investors and industry partners.

The company's core product is LuminLogic NextGen, an AI-enabled electronic Quality Management System (eQMS) and Regulatory Compliance Platform. Underlying components include LuminLogic IQ (an AI-powered regulatory intelligence module supporting knowledge retrieval, process automation, and generative AI), a structured Knowledge Base, and the Elsa & AI Resource Center for AI/ML SaMD compliance content. The platform is designed to host QMS records, design history files, and regulatory submission workflows for medical device manufacturers.

MethodSense monetizes through three streams: (1) regulatory and quality consulting engagements, (2) SaaS licensing of the LuminLogic platform, and (3) a recently launched Capital & Investment Strategy Advisory practice targeting VC, PE, and strategic acquirers. Pricing is quote-based with multi-year contracts and flexible engagement models. Geographic reach is extended through an affiliate network including mdi Europa (EU) and Klass Consulting (Turkey/Russia), and the firm has been recognized with a Global Reach Award from the North Carolina Governor. Recent strategic emphasis has been on commercializing the LuminLogic platform, scaling investor-facing advisory services, and building partner channels within the medtech investment ecosystem.

MethodSense firmographics

Firmographics
Name
MethodSense
Legal name
MethodSense, Inc.
Website
https://methodsense.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
MethodSense is a regulatory and quality consulting firm serving medical device companies via LuminLogic, an AI-enabled eQMS and compliance platform, alongside FDA, EU MDR, and ISO advisory services.
Ownership category
akta.pro rank

MethodSense industry classification

Industry
Product category
Medical Device Regulatory Compliance
NAICS
Management Consulting Services (54161), Computer Systems Design Services (541512)
SIC
Services-Management Consulting Services (8742), Services-Prepackaged Software (7372)
akta.pro primary industry
Regulatory Operations & Publishing (eCTD, RIM, Submission Management) (HLAGAKAC)
akta.pro secondary industries
Regulatory Affairs & Submissions FSP (HLAGAOAD), Regulatory Submissions & Clinical Content Management (eCTD/Publishing) (HLACAOAN)

Keywords

  • Medical device regulatory consulting
  • Quality management systems
  • FDA submission support
  • EQMS compliance software
  • MedTech commercialization services

Where MethodSense is headquartered

Location

Headquarters

HQ city
Morrisville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

MethodSense business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

  1. Regulatory & Quality Consulting Services: Professional consulting services for regulatory strategy, FDA submissions, quality management systems, and compliance support. Delivered through embedded support, project-based consulting, fractional expertise, and on-call guidance models.
  2. LuminLogic Platform Licensing: SaaS licensing of the AI-enabled eQMS and regulatory compliance platform. Organizations can license LuminLogic to continue managing projects, quality systems, and regulatory activities after consulting engagement concludes.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractFlexible engagement models - embedded, project-based, fractional, on-call

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

MethodSense product offering

Product offering

Core offering

MethodSense combines regulatory and quality consulting services with the LuminLogic® NextGen AI-enabled eQMS and Regulatory Compliance Platform purpose-built for medical device organizations. The offering includes regulatory strategy, FDA submissions and clearance support, quality management system implementation, submission disciplines, business strategy, and specialty services in AI/ML, cybersecurity, SaMD, and combination products, supported by a SaaS platform that connects Regulatory, Quality, Engineering, Clinical, Manufacturing, and Leadership teams.

Product overview

MethodSense offers a unified platform-plus-services model centered on LuminLogic® NextGen, an AI-enabled eQMS and Regulatory Compliance Platform purpose-built for medical device companies. The platform combines more than 25 years of regulatory, quality, and commercialization expertise into connected workflows. Key components include LuminLogic IQ (AI-powered intelligence module), the Knowledge Base service, and integrated consulting services spanning Regulatory Strategy & Product Clearance, Quality Management & Business Operations, Submission Disciplines and Support, Business Strategy & Project Management, Capital & Investment Strategy for MedTech, and Specialty Services (AI/ML Validation, Cybersecurity, IEC 60601-1, Combination Products). The platform enables real-time executive visibility through live dashboards and maintains complete traceability across the product lifecycle from concept to clearance.

Differentiator

Problem solved

Functional benefit

Brands

  • LuminLogic: AI-enabled eQMS and Regulatory Compliance Platform purpose-built for medical device companies. Developed by MethodSense, it captures more than 25 years of regulatory, quality, and commercialization expertise. LuminLogic is a registered trademark of MethodSense, Inc.

Products and services

  • LuminLogic NextGen AI-enabled eQMS and Regulatory Compliance Platform purpose-built for medical device organizations. Connects Regulatory, Quality, Engineering, Clinical, Manufacturing, and Leadership teams through a single operational platform with AI-powered intelligence, connected workflows, and real-time executive visibility.
  • LuminLogic Knowledge Base Enhanced knowledge base service on the LuminLogic platform that supports regulatory documentation, content management, and information retrieval across the product lifecycle.
  • Regulatory Strategy and Product Clearance Consulting Professional consulting services for regulatory strategy, FDA submission preparation, pathway determination, and product clearance for medical device companies. Delivered through embedded, project-based, fractional, and on-call engagement models.
  • Quality Management and Business Operations Consulting Consulting services for quality management system (QMS) implementation, ISO 13485 certification, internal gap assessments, supplier oversight, and operational process improvements for medical device companies.
  • Submission Disciplines and Support Consulting Consulting services supporting FDA, EU MDR, eSTAR, ISO 13485, and other global submissions including 510(k), CE Mark, and stalled submission recovery for medical device companies.
  • Capital and Investment Strategy Advisory for MedTech Advisory practice aligning regulatory intelligence with fundable growth and confident capital deployment for the MedTech sector, supporting investors and MedTech companies on regulatory due diligence, QMS documentation review, acquisition preparation, and valuation support.
  • Specialty Services (AI/ML Validation, Cybersecurity, IEC 60601-1, Combination Products) Specialty consulting services covering AI/ML validation, cybersecurity compliance, IEC 60601-1, combination products, SaMD, and software lifecycle documentation for medical device companies.

Quantifiable outcome

  • Reduced time-to-clearance by up to 40%
  • +3 more outcomes

Companies that use MethodSense

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles5 records

MethodSense technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

MethodSense partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and supporting.

  • mdi Europa GmbHcoreChannel Partner/ Reseller/ Distributormdi Europa serves as European Authorized Representative, helping global medical device manufacturers meet EU MDR and IVDR requirements. Their experienced team has supported CE Marking for hundreds of companies, from startups to established brands. Partnership enables MethodSense to offer comprehensive EU market access support.
  • Klass ConsultingcoreChannel Partner/ Reseller/ DistributorKlass Consulting helps medical device companies enter European markets, Turkey, and Russia. Core services include distributor identification and management, as well as reimbursement and global marketing strategy support. Extends MethodSense's European market entry capabilities.
  • Medical Equipment Compliance Association, LLCsupportingImplementation/ SI/ Consulting PartnerProvides evaluation, testing, and compliance reporting for FDA, Health Canada, and international regulatory bodies, supporting CE Marking and global approvals. Complements MethodSense's regulatory and quality services with testing and compliance assessment capabilities.
  • Clinical Research Organizations (CROs)supportingStrategic or Co-development PartnerClinical research partners supporting clinical strategy, trial design, execution, and data analysis. Extend MethodSense's capability to support clinical evidence generation for regulatory submissions.
  • Human Factors and Usability Engineering ExpertssupportingImplementation/ SI/ Consulting PartnerPartners ensuring products are safe, effective, and user-centered through research and validation. Support usability studies and human factors documentation for regulatory submissions.
  • Software Development and Validation SpecialistssupportingTechnology or IntegrationSpecialists guiding compliant development and verification of software as a medical device (SaMD) and embedded systems. Support cybersecurity and software lifecycle documentation.
  • Quality System Auditors and Training ProviderssupportingImplementation/ SI/ Consulting PartnerPartners strengthening internal processes with audits, gap assessments, and customized staff training. Extend MethodSense's quality management system implementation capabilities.

Scale indicators6 records

Recent moves6 records

Expansion highlights12 records

MethodSense competitors and assessment

Company assessment

Broad incumbents

  • Veeva Systems: Veeva is a large, publicly traded life sciences cloud platform with quality, regulatory, and clinical suites used by major MedTech and pharma companies — a broader incumbent competing for the same enterprise eQMS and RIM budgets as LuminLogic.
  • IQVIA: IQVIA is a global CRO and life sciences services giant with extensive regulatory affairs consulting capabilities — comparable to MethodSense's professional services arm and competing for the same MedTech regulatory outsourcing spend.
  • Medidata Solutions (Dassault Systèmes): Medidata, part of Dassault Systèmes, provides clinical and regulatory platforms for life sciences organizations — a broad incumbent whose regulatory and submission tools overlap with portions of the LuminLogic platform.

Direct peers

  • MasterControl: MasterControl provides enterprise-grade eQMS, document control, and regulatory submission management for life sciences manufacturers, including dedicated MedTech modules — competing with LuminLogic in the same procurement cycles.
  • Rimsys Regulatory Affairs Software: Rimsys offers SaaS for medical device regulatory affairs, including submission planning, registration tracking, and standards management — a direct competitor to MethodSense's submission automation and eSTAR support capabilities.
  • ProPharma Group: ProPharma Group provides regulatory, compliance, and quality consulting across pharma and MedTech, including FDA submission support and QMS implementation — directly comparable to MethodSense's consulting service lines.
  • Greenlight Guru: Greenlight Guru is a MedTech-specific eQMS and quality management platform offering similar SaaS-based regulatory and quality workflows for medical device companies — directly comparable to MethodSense's LuminLogic offering.
  • Regulatory Compliance Associates (RCA): RCA specializes in regulatory affairs and quality system consulting for medical device and life sciences companies, including FDA submissions and ISO 13485 — a direct peer to MethodSense's core consulting practice.
  • NAMSA: NAMSA is a MedTech-focused CRO and regulatory consulting firm offering preclinical, clinical, and regulatory services to medical device manufacturers — overlapping with MethodSense's regulatory strategy and submission support offerings.

Emerging players

  • Dot Compliance: Dot Compliance delivers AI-powered, ready-to-use eQMS solutions on the Salesforce platform for life sciences — an emerging competitor to LuminLogic with a similar AI-augmented quality and compliance positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

MethodSense social profiles

Digital presence

MethodSense financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MethodSense leadership team

Management profile

Number of profiles

Profiles4 records

MethodSense funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MethodSense M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MethodSense

What does MethodSense do?

MethodSense combines regulatory and quality consulting services with the LuminLogic® NextGen AI-enabled eQMS and Regulatory Compliance Platform purpose-built for medical device organizations. The offering includes regulatory strategy, FDA submissions and clearance support, quality management system implementation, submission disciplines, business strategy, and specialty services in AI/ML, cybersecurity, SaMD, and combination products, supported by a SaaS platform that connects Regulatory, Quality, Engineering, Clinical, Manufacturing, and Leadership teams.

Is MethodSense a public or private company?

MethodSense is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was MethodSense founded?

MethodSense was founded in 2000. It employs 11 to 50 people.

Where is MethodSense based?

MethodSense is headquartered in Morrisville, United States, in the North America region.

How does MethodSense make money?

Two revenue lines are on record. Regulatory & Quality Consulting Services are the primary driver. The others are luminLogic Platform Licensing.

Who are MethodSense's main competitors?

Broad incumbents on record are Veeva Systems, IQVIA and Medidata Solutions (Dassault Systèmes). Direct peers are MasterControl, Rimsys Regulatory Affairs Software, ProPharma Group, Greenlight Guru, Regulatory Compliance Associates (RCA) and NAMSA. Dot Compliance is listed as an emerging player.

Does MethodSense have an API?

No public API is recorded for MethodSense.

What industry is MethodSense in?

MethodSense's product category is Medical Device Regulatory Compliance. Its primary akta.pro industry code is HLAGAKAC, Regulatory Operations & Publishing (eCTD, RIM, Submission Management), with a secondary code of HLAGAOAD, Regulatory Affairs & Submissions FSP. Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Med-Tech InsightsMethodSense launches LuminLogic NextGen to transform MedTech complianceMethodSense launched LuminLogic NextGen, an AI-enabled quality and regulatory compliance platform unifying eQMS, regulatory intelligence, and submission readiness. The platform is trained on 25+ years of MethodSense methodologies and is already helping clients like OxiWear accelerate development.EIN PresswireMethodSense Launches Capital & Investment Strategy Advisory for the MedTech SectorMethodSense, a regulatory and quality consulting firm specializing in medical devices, announced the launch of its Capital & Investment Strategy advisory practice for the MedTech sector. The new practice integrates regulatory intelligence with capital alignment to support companies raising capital, investors, and boards overseeing challenged assets. Richard Holcomb, Chief Growth Officer with over 40 years of experience in capital formation and M&A, will lead the initiative, which is supported by MethodSense's LuminLogic compliance intelligence platform.EIN PresswireMethodSense Receives Global Reach Award for Trade Excellence from NC Governor Stein and EDPNCMethodSense, a North Carolina-based regulatory and quality advisory firm serving the medical device and life sciences industry, received the Global Reach Award for Export Trade Excellence from Governor Josh Stein and the Economic Development Partnership of North Carolina (EDPNC). The award recognizes the company's strategic export planning, participation in trade delegations, and its LuminLogic compliance platform that supports regulatory submissions and quality systems across global markets including North America, Europe, Middle East, Southeast Asia, and Asia-Pacific. CEO Rita King stated the recognition affirms that North Carolina companies can lead in high-value global services and technology.The Florida Times-UnionMethodSense Supports ulrich medical to Fourth FDA Clearance for Innovative Computed Tomography (CT) Injector SystemMethodSense, Inc. announced that its client ulrich medical has received its fourth FDA clearance for the CT Motion Injector System, a next-generation syringe-less injector for diagnostic imaging, marking over a decade of regulatory collaboration between the two firms. The cleared system introduces significant advancements including extended disposable usability of up to 24 hours, expanded pharmaceutical capacity supporting up to 36 contrast media bottles per pump tubing, and a new automated contrast medium density function. ulrich medical, headquartered in Germany, has expanded its U.S. market share since its first FDA submission in 2017, growing beyond the FDA's small business designation.Enterprise NewsMethodSense Supports ulrich medical to Fourth FDA Clearance for Innovative Computed Tomography (CT) Injector SystemMethodSense supported ulrich medical in obtaining the fourth FDA clearance for its CT Motion Injector system, a diagnostic imaging device, in 2026. The clearance highlights key product features like increased usability, capacity, and software enhancements, which improve safety and efficiency in radiology departments.The Topeka Capital-JournalMethodSense Supports ulrich medical to Fourth FDA Clearance for Innovative Computed Tomography (CT) Injector SystemMethodSense, a regulatory and quality consulting firm, announced that its client ulrich medical has received its fourth FDA clearance for the CT Motion Injector, a next-generation syringe-less CT injector system designed for diagnostic imaging. The cleared device nearly doubles efficiency over prior models, with extended disposable usability of up to 24 hours, support for up to 36 contrast media bottles per pump tubing, and a new automated software function called CDadapt that autonomously adjusts contrast media density. The milestone marks more than a decade of collaboration between the two companies since 2012, during which ulrich medical expanded its U.S. market share and product portfolio.The Fayetteville ObserverMethodSense Supports ulrich medical to Fourth FDA Clearance for Innovative Computed Tomography (CT) Injector SystemMethodSense, a regulatory and quality consulting firm for medical devices, announced that its client ulrich medical received its fourth FDA clearance for the CT Motion Injector, a next-generation syringe-less injector system for diagnostic imaging. The newly cleared system featuring extended 24-hour disposable usability, expanded pharmaceutical capacity supporting 36 contrast media bottles, and automated contrast medium density adjustment nearly doubles the efficiency of prior models. The milestone represents more than a decade of collaboration, with ulrich medical expanding its U.S. market share since its first FDA submission in 2017.The Stockton RecordMethodSense Supports ulrich medical to Fourth FDA Clearance for Innovative Computed Tomography (CT) Injector SystemMethodSense, a regulatory consulting firm, announced that its client ulrich medical has received its fourth FDA clearance for the CT Motion Injector System, a next-generation syringe-less injector used in diagnostic imaging. The newly cleared system features extended disposable usability (up to 24 hours), expanded pharmaceutical capacity (36 contrast media bottles per pump tubing), and automated contrast medium density adjustment, nearly doubling the efficiency of prior models. The clearance reflects more than a decade of collaboration between the two companies, with ulrich medical expanding its U.S. market share since its first FDA submission in 2017.TodaysmedicaldevelopmentsSyringe-less injector system for diagnostic imaging obtains fourth FDA clearanceMethodSense, Inc. announced that its client ulrich medical received its fourth FDA clearance for the ulrich medical CT Motion Injector, a next-generation syringe-less injector system used in diagnostic imaging, representing another milestone in their more than decade-long partnership. The newly cleared system introduces several advancements including extended disposable usability (up to 24 hours versus the previous 8 hours), expanded pharmaceutical capacity supporting up to 36 contrast media bottles per pump tubing (nearly doubling throughput), and an automated contrast medium density function called CDadapt, which together nearly double the efficiency of prior models. Ulrich medical has expanded its U.S. market share and product portfolio since its first FDA submission in 2017, growing beyond the FDA's small business designation.York Daily RecordMethodSense Supports ulrich medical to Fourth FDA Clearance for Innovative Computed Tomography (CT) Injector SystemMethodSense supported ulrich medical in obtaining its fourth FDA clearance for the CT Motion Injector, a syringe-less system used in diagnostic imaging. The clearance highlights improvements in safety, efficiency, and compatibility, and reflects a long-standing partnership that began in 2012.